The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus
Open accessAbstract
BACKGROUND: Early termination of prolonged seizures with intravenous administration of benzodiazepines improves outcomes. For faster and more reliable administration, paramedics increasingly use an intramuscular route. METHODS: This double-blind, randomized, noninferiority trial compared the efficacy of intramuscular midazolam with that of intravenous lorazepam for children and adults in status epilepticus treated by paramedics. Subjects whose convulsions had persisted for more than 5 minutes and who were still convulsing after paramedics arrived were given the study medication by either intramuscular autoinjector or intravenous infusion. The primary outcome was absence of seizures at the time of arrival in the emergency department without the need for rescue therapy. Secondary outcomes included endotracheal intubation, recurrent seizures, and timing of treatment relative to the cessation of convulsive seizures. This trial tested the hypothesis that intramuscular midazolam was noninferior to intravenous lorazepam by a margin of 10 percentage points. RESULTS: At the time of arrival in the emergency department, seizures were absent without rescue therapy in 329 of 448 subjects (73.4%) in the intramuscular-midazolam group and in 282 of 445 (63.4%) in the intravenous-lorazepam group (absolute difference, 10 percentage points; 95% confidence interval, 4.0 to 16.1; P<0.001 for both noninferiority and superiority). The two treatment groups were similar with respect to need for endotracheal intubation (14.1% of subjects with intramuscular midazolam and 14.4% with intravenous lorazepam) and recurrence of seizures (11.4% and 10.6%, respectively). Among subjects whose seizures ceased before arrival in the emergency department, the median times to active treatment were 1.2 minutes in the intramuscular-midazolam group and 4.8 minutes in the intravenous-lorazepam group, with corresponding median times from active treatment to cessation of convulsions of 3.3 minutes and 1.6 minutes. Adverse-event rates were similar in the two groups. CONCLUSIONS: For subjects in status epilepticus, intramuscular midazolam is at least as safe and effective as intravenous lorazepam for prehospital seizure cessation. (Funded by the National Institute of Neurological Disorders and Stroke and others; ClinicalTrials.gov number, ClinicalTrials.gov NCT00809146.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treiman, D. M. (1996) · PubMed · Cited by 1,024
Alldredge, B. K., Gelb, A. M., Isaacs, S. M., Corry, M. D., Allen, F., Ulrich, S., Gottwald, M. D., O'Neil, N., Neuhaus, J. M., Segal, M. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002141 · Cited by 888
Self-citationLowenstein, D. H., & Alldredge, B. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381407 · Cited by 568
Self-citationDunnett, C. W., & Gent, M. (1977) · Biometrics · doi:10.2307/2529457 · Cited by 389
McMullan, J., Sasson, C., Pancioli, A., & Silbergleit, R. (2010) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2010.00751.x · Cited by 181
Self-citationCHAMBERLAIN, J. M., ALTIERI, M. A., FUTTERMAN, C., YOUNG, G. M., OCHSENSCHLAGER, D. W., & WAISMAN, Y. (1997) · Pediatric Emergency Care · doi:10.1097/00006565-199704000-00002 · Cited by 175
Lahat, E. (1997) · PubMed · Cited by 141
The Prehospital Treatment of Status Epilepticus (PHTSE) Study
Lowenstein, D. H., Alldredge, B. K., Allen, F., Neuhaus, J. M., Corry, M. D., Gottwald, M. D., O'Neil, N., Ulrich, S., Isaacs, S. M., & Gelb, A. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00120-9 · Cited by 64
Self-citationEmergency Treatment of Status Epilepticus: Current Thinking
Millikan, D., Rice, B. T., & Silbergleit, R. (2009) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.12.001 · Cited by 52
Self-citationPrehospital stability of diazepam and lorazepam
Gottwald, M. D., Akers, L., Liu, P.-K., Orsulak, P. J., Corry, M. D., Bacchetti, P., Fields, S., Lowenstein, D. H., & Alldredge, B. K. (1999) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(99)90079-7 · Cited by 51
Self-citationMidazolam andDiazepam for Pediatric Seizures in the Prehospital Setting
Warden, C. R., & Frederick, C. (2006) · Prehospital Emergency Care · doi:10.1080/10903120600885126 · Cited by 36
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Glauser, T., Shinnar, S., Gloss, D., Alldredge, B., Arya, R., Bainbridge, J., Bare, M., Bleck, T., Dodson, W. E., Garrity, L., et al. (2016) · Epilepsy Currents · doi:10.5698/1535-7597-16.1.48 · Cited by 1,280
Self-citationMoshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Kapur, J., Elm, J., Chamberlain, J. M., Barsan, W., Cloyd, J., Lowenstein, D., Shinnar, S., Conwit, R., Meinzer, C., Cock, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905795 · Cited by 551
Self-citationBetjemann, J. P., & Lowenstein, D. H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00042-3 · Cited by 495
Self-citation
Metadata
- Authors
- Silbergleit, R., Durkalski, V., Lowenstein, D., Conwit, R., Pancioli, A., Palesch, Y., & Barsan, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-02-16
- Volume
- 366
- Issue
- 7
- Pages
- 591-600
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2151359410
- Cited by
- 744
- References
- 11
- FWCI
- 46.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.